Clinical Trials Browser

Phase 2 × pembrolizumab × Myeloid × Clear all

NCT03065400 2021-06-21

PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

Phase 2 Completed

10 enrolled 7 charts

Polycythemia Vera, Primary Myelofibrosis